Accelerate Commercialization News Today

Industry Veteran Bjorn Hansson Joins Company to Accelerate Commercialization of Revolutionary Optical Sensor Platform

/PRNewswire/ -- The "Supercapacitors: Global Strategic Business Report" report has been added to ResearchAndMarkets.coms offering. Global Supercapacitors...

CoTec Holdings Making Anchor Investment to Accelerate Commercialization of International Zeolite's Revolutionary Proprietary NEREA(R) Fertilizer Technology Vancouver, British Columbia--(Newsfile Corp.

/PRNewswire/ -- The "Supercapacitors - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.coms offering. Supercapacitors, also...

/PRNewswire/ -- The "Global Robotic Exoskeletons Market Trends and Opportunities Report 2021" report has been added to ResearchAndMarkets.coms offering. The...

MindMaze, a SaaS-based digital neurotherapeutics platform raises $125M led by AlbaCore Capital Group to expand neuro-rehabilitation platform.

Share: Autonomous Trucking Technology Company Plans to Start Mass Production in 2021 Proprietary Full-Stack Level 4 ("L4") Software is Behind the Decision-Making Required to Autonomously, Safely and Intelligently Drive the Vehicle Post-Combination Represents Market Capitalization of $3.3 Billion for Plus Plus to Add Up to Approximately $500 Million in Gross Proceeds to Accelerate Commercialization and Expand Global Operations Transaction Supported by $150 Million PIPE, Including Investments Fro...

Mar 5, 2021 11:20am Roches Actemra has become the first biologic that the FDA approved for patients with systemic sclerosis-associated interstitial lung disease. (Roche/Genentech) Missed the primary endpoint of a clinical trial? No problem. We’ll pick the study apart and approve your drug based on a post-hoc subgroup analysis. That’s what the FDA did in granting Roche’s Actemra a go-ahead in patients with interstitial lung disease (ILD) associated with the rare autoimmune disease syste...

Mar 5, 2021 11:23am Novartis Kymriah is ready for new CAR-T competition from Bristol Myers Squibb, an exec said. (Novartis) With the FDA’s recent approval for Bristol Myers Squibb’s Breyanzi, a new pharma giant is entering the CAR-T lymphoma fray. But with new, impressive real-world data and a global manufacturing expansion under its belt, rival Novartis says its ready to rumble. Novartis last year opened CAR-T production sites in Switzerland and France, while a partner opened a facility�...

Mar 3, 2021 9:55am Novartis presented positive study data at the sixth annual Americas Committee for Treatment and Research in Multiple Sclerosis Forum from nurses and patients using its Kesimpta auto-injector pen for MS. (Novartis) Novartis nabbed FDA approval for Kesimpta to treat multiple sclerosis last year, but now it’s getting the thumbs-up from MS patients and nurses. Novartis presented study data at the sixth annual Americas Committee for Treatment and Research in Multiple Sclerosis...